1. |
Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 2018, 390(10100): 1151-210.
|
2. |
World Health Organization (WHO) Chronic obstructive pulmonary disease (COPD), Fact sheet December 2022 [Internet]. 2022. [cited Sep. 9th, 2022]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
|
3. |
Burney P, Jarvis D, Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis, 2015, 19(1): 10-20.
|
4. |
Weng C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the ChinaPulmonary Health [CPH] study): a national cross-sectionalstudy. Lancet, 2018, 391(10131): 1706-1717.
|
5. |
Celli BR, Wedzicha JA. Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 2019, 381(13): 1257-66.
|
6. |
Gao JT, Liu YH. Key points of the 2020 WHO global tuberculosis report. J Hebei Med Univ, 2021, 42(1): 1-6.
|
7. |
Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide screening for tuberculosis in a high-prevalence setting. N Engl J Med, 2019, 381(14): 1347-1357.
|
8. |
O'Toole RF, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease. Tuberculosis (Edinb). 2015 Dec;95(6): 659-663.
|
9. |
Chakrabarti B, Calverley PM, DaviesPD. Tuberculosis and itsincidence, special nature, and relationship with chronicobstructive pulmonary disease. Int J Chron Obstruct PulmonDis, 2007, 2(3): 263-272.
|
10. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版). 中华结核和呼吸杂志, 2021, 44(3): 170-205.
|
11. |
中华医学会结核病学分会. 肺结核诊断和治疗指南. 内科急危重症杂志, 2002, 8(4): 225-229.
|
12. |
中华人民共和国国家卫生和计划生育委员会. WS 196-2017结核病分类[S/OL]. (2017- 12-12)[2018-02-07]. http: //www. nhfpc. gov. cn/ewebeditor/uploadflle/2017/12/201 71212154717348. pdf.
|
13. |
中华人民共和国国家卫生和计划生育委员会. WS 288-2017肺结核诊断[S/OL]. (2018-01-16)[2018-02-07]. http://www.nhfpe.gov.cn/zwgkzt/s9491/20080l/38801/files/987acb0232964cala9dcf833adl26a31.pdf.
|
14. |
黄平. 结核病相关阻塞性肺疾病患者血清炎症水平及气道阻塞程度的研究. 青海大学, 2022.
|
15. |
van Kampen SC, Wanner A, Edwards M, et al. Internationalresearch and guidelines on post-tuberculosis chronic lungdisorders: a systematic scoping review. BMJ Glob Health, 2018, 3: e000745.
|
16. |
万鹏飞, 徐静, 陈华萍, 等. 慢性阻塞性肺疾病合并肺结核的临床特征及危险因素分析. 中华肺部疾病杂志(电子版), 2021, 14(6): 741-744.
|
17. |
陈华萍, 胡明冬, 张君国, 等. 慢性阻塞性肺疾病合并症及其对预后的影响. 解放军医学杂志, 2020, 45(8): 834-839.
|
18. |
Kamenar K, Hossen S, Gupte AN, et al. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax. 2022;77(11): 1088-1097.
|
19. |
宋建奎, 杨绍明, 姚骋, 等. 肺结核合并慢性阻塞性肺疾病流行病学特征. 中国防痨杂志, 2007(4): 370-371.
|
20. |
尹洪云, 许家琏. 慢性阻塞性肺病与肺结核的关系. 中国临床医生, 2004(8): 12-14.
|
21. |
Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol, 2014, 2(9): 740-753.
|
22. |
周伊南, 朱惠莉. 慢性阻塞性肺疾病合并肺结核的研究进展. 结核与肺部疾病杂志, 2022, 3(4): 338-342.
|
23. |
Park HJ, Byun MK, Kim HJ, et al. Histo-ry of pulmonary tuberculosis affects the severity and clinical outcomes of COPD. Respirology, 2018, 23(1): 100-106.
|
24. |
Ma L, Gao M. Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease. Infect Drug Resist, 2022, 15: 4861-4869.
|
25. |
刘盼盼. 慢性阻塞性肺疾病急性加重合并活动性肺结核的临床特点分析及早期诊断探讨. 石河子大学, 2017.
|
26. |
尚丹鹤, 乔凯. 慢性阻塞性肺病合并肺结核患者免疫功能变化分析. 河南医学高等专科学校学报, 2022, 34(3): 278-281.
|
27. |
Zavala MJ, Becker GL, Blount RJ. Interrelationships between tuberculosis and chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2023, 29(2): 104-111.
|
28. |
贾钦尧, 宋珊, 程耀, 等. 慢性阻塞性肺疾病患者合并肺结核的影响因素分析及其列线图预测模型的建立. 中国感染与化疗杂志, 2023, 23(1): 47-52.
|
29. |
Lönnroth K, Williams BG, Cegielski P, et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol, 2010, 39(1): 149-155.
|
30. |
Prescott E, Almdal T, Mikkelsen KL, et al. Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J, 2002, 20(3): 539-544.
|
31. |
Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia. PLOS ONE, 2015, 10(12): e0144244.
|
32. |
Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr, 2012, 95(6): 1385-1395.
|
33. |
Sinclair D, Abba K, Grobler L, et al. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2011(11): Cd006086.
|
34. |
秦玉姣. 慢性阻塞性肺疾病合并支气管扩张的临床特征及相关因素分析. 吉林大学, 2018.
|